CRIS Current Research Information System

GADDI, ANTONIO VITTORINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.351
NA - Nord America 5.648
AS - Asia 4.468
SA - Sud America 342
AF - Africa 260
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 8
Totale 29.092
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 12.318
US - Stati Uniti d'America 5.609
DE - Germania 1.524
CN - Cina 1.443
GB - Regno Unito 1.414
SG - Singapore 1.393
NL - Olanda 749
VN - Vietnam 662
SE - Svezia 513
UA - Ucraina 506
HK - Hong Kong 333
FR - Francia 306
IN - India 284
RU - Federazione Russa 284
BR - Brasile 248
IE - Irlanda 166
CH - Svizzera 137
KR - Corea 112
JP - Giappone 109
ZA - Sudafrica 105
EE - Estonia 86
CI - Costa d'Avorio 54
PL - Polonia 51
BE - Belgio 47
SC - Seychelles 43
AR - Argentina 40
FI - Finlandia 40
BG - Bulgaria 34
TG - Togo 34
ES - Italia 32
GR - Grecia 30
RO - Romania 27
CA - Canada 22
TR - Turchia 20
AL - Albania 19
JO - Giordania 18
ID - Indonesia 16
MX - Messico 14
AT - Austria 13
AU - Australia 13
EC - Ecuador 13
CL - Cile 11
HR - Croazia 10
IQ - Iraq 10
BD - Bangladesh 9
CO - Colombia 8
EG - Egitto 8
CZ - Repubblica Ceca 7
PE - Perù 7
LB - Libano 6
MA - Marocco 6
MC - Monaco 6
MY - Malesia 6
NO - Norvegia 6
TW - Taiwan 6
EU - Europa 5
HU - Ungheria 5
IR - Iran 5
LU - Lussemburgo 5
PK - Pakistan 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
PY - Paraguay 4
SI - Slovenia 4
TH - Thailandia 4
UY - Uruguay 4
AZ - Azerbaigian 3
BY - Bielorussia 3
GE - Georgia 3
KZ - Kazakistan 3
TN - Tunisia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DZ - Algeria 2
MT - Malta 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
BO - Bolivia 1
BS - Bahamas 1
CM - Camerun 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GY - Guiana 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LT - Lituania 1
MN - Mongolia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
SN - Senegal 1
TJ - Tagikistan 1
TL - Timor Orientale 1
Totale 29.091
Salva come PNG Salva come JPEG
Città #
Milan 1.208
Southend 1.199
Rome 901
Singapore 847
Fairfield 498
Ashburn 494
Chandler 471
Santa Clara 412
Hefei 381
Naples 366
Frankfurt am Main 356
Jacksonville 351
Hong Kong 329
Turin 285
Princeton 270
Wilmington 261
Bologna 258
Seattle 239
Woodbridge 238
Florence 230
Dong Ket 195
Ann Arbor 189
Padova 186
Düsseldorf 172
Houston 168
Cambridge 160
Dublin 160
Palermo 159
Boardman 152
Bari 138
Verona 120
Nanjing 119
Westminster 117
Ho Chi Minh City 113
Beijing 112
Tokyo 107
Seoul 106
Hanoi 97
Catania 95
Genoa 91
Berlin 87
Buffalo 79
Los Angeles 79
Brescia 73
Parma 71
Saint Petersburg 69
Medford 59
Bremen 58
Cagliari 58
Abidjan 54
Modena 54
Pescara 52
Dallas 51
Mülheim 51
Perugia 45
Mahé 41
Shenyang 41
Hebei 40
Jinan 40
Monza 39
Brussels 38
Nanchang 38
Vicenza 38
Venice 37
Dearborn 35
Bern 34
Lomé 34
Livorno 33
Reggio Emilia 33
Sofia 32
Helsinki 31
Bengaluru 30
Trento 30
Changsha 29
San Diego 29
Warsaw 29
New York 27
Ancona 26
Guangzhou 26
Shanghai 26
Bergamo 25
Montesilvano Marina 25
Taranto 25
São Paulo 24
Mountain View 23
San Venanzo 23
Trieste 23
Como 22
Redwood City 22
Meda 21
Treviso 21
Zurich 21
Cesena 20
Messina 19
Paris 19
Yubileyny 19
Zhengzhou 19
Amman 18
Olalla 18
Pune 18
Totale 14.551
Salva come PNG Salva come JPEG
Nome #
La fame d’amore: un bambino che sta bene non piange. 12.607
Regressione completa di xantelasmi palpebrali in seguito a prolungatra terapia con statine: Case Report 1.674
Assessment of the health status in the Massa Lombarda cohort: a preliminary description of the program evaluating cardio-cerebro-vascular disease risk factors and quality of life in an elderly population. 254
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy 200
Effects of Siberian ginseng (Eleutherococcus senticosus maxim.) on elderly quality of life: a randomized clinical trial. 195
Wath are the major risk factors for type II diabetes development in the historical cohort of the Brisighella heart study? A 16-years follow-up 189
Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial. 176
Treatment of massive hypertriglyceridemia resistant to PUFA and fibrates: a possible role for the coenzyme Q10? 173
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome. 171
Epidemiologia delle malattie cerebrovascolari. 169
Linkage disequilibrium patterns and tagSNP transferability among European populations. 168
Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates. 168
Prevalence and the relative role of the main predictors of metabolic syndrome development in the hystorical cohort of the Brisighella heart study: 16-years follow-up 167
Changes in LDL fatty acid composition as a response to olive oil treatment are inversely related with the lipid oxidative damage: the EUROLIVE Study. 166
Effects of a new low dose soy protein β-sitosterol association on plasma lipid levels and oxidation 163
A comparison study of Lp(a) plasma levels distributions between normo- and hypertensive subjects with high BMI. 163
Long-term effect of glimepiride and rosiglitazone on non-conventional cardiovascular risk factors in metformin-treated patients affected by metabolic syndrome: a randomized, double-blind clinical trial. 162
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome. 162
Sources of variabilità of plasma HDL-cholesterol levels. 159
Relative role of major risk factors for Type 2 Diabetes development in the historical cohort of the Brisighella Heart Study: an 8-years follow-up. 157
Software per l'identificazione automatica delle iperlipoproteinemie genetiche 155
Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone. 154
REVERSAL and PROVE-IT: are clinically oriented trials really better than "pure" scientific studies? 151
Efficacia della supplementazione dietetice con fibre solubili nelle gestione del rischio delle malattie cardiovascolari di pazienti affetti da SM: un trial clinico randomizzato open label di un anno 149
Metabolic Syndrome prevalence in Italy. 149
Prevalenza e determinati clinico-laboratoristici della sindrome metabolica in un campione di soggetti in età geriatrica: il Brisighella Heart Study 148
Prevalence of metabolic syndrome in working population: preliminary results fo a campaign of cardiovascular risk screening 147
Iperlipoproteinemia familiare combinata: complicanze cardiovascolari e cerebrovascolari 139
Proteine della Soia. Effetti metabolici e ruolo nella prevenzione cardiovascolare 139
Effect of olive oils on biomarkers of oxidative DNA stress in Northern and Southern Europeans. 136
Elevated circulating LDL phenol levels in men who consumed virgin rather than refined olive oil are associated with less oxidation of plasma LDL. 136
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride. 135
Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensives. 135
A dietary education program involving the general population balances the effects of menopause on cardiovascular risk factors and metabolic syndrome incidence: data from the Brisghella Heart Study 132
Development of an UHPLC-diode arrays detector (DAD) method for the analysis of polydatin in human plasma 132
Temporal trend of antihypertensive drugs therapy and blood pressure control in the Brisighella Heart Study. 131
Novel mutation in the ApoB Gene (Apo B-15.56): A Case Report. 130
Osservazioni clinico sperimentali su possibili relazioni tra andamento dei valori sierici di creatinina kinasi e colesterolo LDL in pazienti asintomatici con ipercoelsterolemia ed elevati livelli di CPK in corso di terapia con statine. 130
Case Report: lipoproteina (A) is an indipendent risk factor for coronary artery disease: diagnosis and follow-up of a patient with high level of Lp(a) as only cardiovascular risk factor 129
The influence of statin medications on Prostate Specific Antigen levels. 128
BlueC@rdio 128
Effect of a dietary education program on plasma lipid level in a rural setting: the Brisighella Heart Study 128
Physical activity, exercise and cardiovascular health 126
Physical activity and cardiovascular disease mortality: the Brisighella heart study 124
Attività fisica e aterosclerosi: i dati di Brisghella 124
Coenzyne Q10 effect on the serum creatinine increase associated to rosuvastatin 20 mg in severe hypercholesterolemic patients 124
A nutraceutical based approach to reduce cholesterolemia in patients previously intolerant to more than a statin: a pilot study. 121
Psychosocial factors and metabolic parameters: is there any association in elderly people? The Massa Lombarda Project 121
The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. 120
Clinical perspectives of anti-inflammatory therapy in the elderly: the lipoxigenase (LOX)/cycloxigenase (COX) inhibition concept. 120
Moderate consumption of olive oil by healthy European men reduces systolic blood pressure in non-Mediterranean participants. 117
Criteri di appropriatezza clinica, tecnologica e strumentale nell'assistenza alle malattie del sistema cardiovascolare 117
Massa Lombarda Project (Prevention and control of cardiovascular diseases: Instant Individual Definition and Bluc@ardio Project) 117
What herbalists suggest to our diabetic patients in order to improve their glycaemic control? Evaluation of scientific evidences and potential risks. 117
Primary variation in serum HDL-cholesterol levels: an independent cardiovascular risk factor in healthy adults? 116
Otoscopic findings in hypercholesterolemic subjects 116
Modification of the dietary habits in the Brisighella Heart Study 114
Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date. 113
Effect of Sulodexide on Albuminuria, NAG Excretion and Glomerular Filtration Response to Dopamine in Diabetic Patients. 113
Assocaition between hyperCKPemia and hypercholesterolemia in general population: casual phenotype or genic cluster? 112
Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardio-vascular disease: response to Beishuizen et al. 112
Observation of possibly relations between trend of CPK levels and LDL cholesterol in patients with hypercholesterolemia and asymptomatic primary high level of creatinechinase under statin therapy 112
Treatment of peripheral obstructive artery disease: a battle that could be winned also with drugs? [Trattamento dell'arteriopatia obliterante degli arti inferiori: Una battaglia che può essere vinta anche con i farmaci?] 111
Metabolic Effects of Pioglitazone and Rosiglitazone in patients with diabetes and metabolic syndrome treated with Glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial. 111
Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studies. 111
Confronto di due algoritmi diagnostici nella strima della prevalenza della sindrome metabolica in soggetti in età geriatrica e nella popolazione gnerale: Il Brisighella Heart Study. 110
Complementary and alternative medicine for hypertension. What evidence is there for herbalist suggestions? 110
Otoscopic examination: a diagnostic contribution for atherosclerotic disease? 110
Plasma lipid effects of corn oil and extra-virgin olive oil in hypercholesterolemic subjects: a randomized, controlled trial. 109
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered. 108
Piano Regionale della Prevenzione (2005-2008; volume 44) 106
Brisghella Heart Study (BHS): ipertensione ed obesità. 105
Physical activity trend in a rural population submitted to a nutritional program: the Brisighella Heart Study 104
Main predictors of metabolic syndrome and type 2 diabetes development in the historical cohort of the Brisighella Heart Study: a 16 years follow-up. 104
Gender specific haemodinamic and metabolic effects of a sequential training program on hypertensive overweight patients. 103
MMP-2, MMP-9 and their inhibitors in FCH, MS, FCH+MS and control subjects: a comparison study. 103
Effects of doxazosin and irbesartan on blood pressure and metabolic control in patients with type 2 diabetes and hypertension. 101
eHealth: uno strumento di prevenzione cardiovascolare 100
Regression of atherosclerosis after one year of treatment with low dosed rosuvastatin: the role of patient selection. 100
Obesity related health risk and social cost. 99
EUROLIVE 99
null 98
Role of olive oil in the health: results form the Eurolive Study. 98
null 98
Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study. 98
Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial. 97
Non-pharmacological control of plasma cholesterol levels. 97
Strumenti diagnostici per l’identificazione delle iperlipoproteinemie a base genetica. 96
The relevance of soluble fibre dietary supplement in cardiovacular disease risk menagement of patients affected by metabolic syndrome (MS): a 1-year, open label, randomized clinical trial. 96
Estimating the burden of hyperlipidemia in a hypertensive ambulatory population 96
Causes of statin interruption by hyperlipidaemic patients: the result of survey on 218 consecutive patients. 96
Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study. 96
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial. 95
Metabolic syndrome and prevalence of instrumental atherosclerosis or its clinical complications in 1000 subjects affected by different forms of familial hyperlipoproteinemia. 94
null 93
Incontro sull'eccellenza didattica tra Dodenti della Facoltà di Medicina del Karolinska Institute e dell'Università di Bologna 93
Consapevolezza, trattamento e controllo della pressione artersiosa e modificazioni temporali nell'impiego dei farmaci antiipertensivi. 93
Non conventional cardiovascular risk factors distribution in FCH, MS, FCH+MS and control subjects: towards a full disease characterization. 93
Progetto Best Practice - Ipercolesterolemia (cfr sito) 91
Practical reccomendations for Familial Combined Hyperlipidemia diagnosis and management: an update. 90
Totale 26.652
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.244
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.244
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.292 0 0 0 0 0 154 82 141 175 148 157 435
2021/20222.152 198 88 134 134 210 145 50 152 87 119 456 379
2022/20232.684 302 317 148 346 148 168 123 187 360 136 285 164
2023/20243.543 93 210 122 154 164 230 194 168 242 635 579 752
2024/20259.729 870 1.231 840 823 1.195 665 1.092 640 467 671 444 791
2025/20264.924 717 1.158 919 664 745 721 0 0 0 0 0 0
Totale 29.324